MRK.DE Trial readout: Tuesday, November 24, 2026
CompanyMerck KGaA (MRK.DE)
EventTrial readout
DateTuesday, November 24, 2026
MarketEU listing
SourceCT.gov registry · confidence 95% · primary source ↗
Est. Completion: 2026-11-24. Status: ACTIVE_NOT_RECRUITING. Title: Avelumab Program Rollover Study
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.